Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1220 in its research report dated January 31, 2023.
Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1220 in its research report dated January 31, 2023. Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1220 in its research report dated January 31, 2023. Moneycontrol Latest News Read More
